The second of four bellwether lawsuits against transvaginal mesh manufacturer C.R. Bard has ended in a settlement. The case was part of federal litigation being heard in the Southern District of West Virginia.
The case involved a North Carolina woman who says she suffered permanent injury from Bard’s Avaulta Solo Anterior Synthetic Support System. She said she underwent six surgeries because of injuries and complications because of the mesh.
Details of the settlement were not released.
Just over a week ago, a jury found Bard liable for the injuries a Georgia nurse sustained from the transvaginal mesh. In testimony, jurors heard how the manufacturer of the resin used to make the mesh warned that their product should not be permanently implanted in humans. Despite the warnings, Bard went ahead with the manufacture and marketing of their transvaginal mesh. The company has been ordered to pay $2 million in that case.
The Avaulta transvaginal mesh was initially approved by the Food and Drug Administration (FDA) through a fast-track approval process. Over the years, this FDA process has allowed several faulty products into the market. Many of them have been recalled.
C.R. Bard is currently facing more than 5000 lawsuits over the company’s transvaginal mesh. In October, a West Virginia courtroom will be the scene of two more bellwether lawsuits that are being used to test theories of the cases and gauge juries’ reactions to the evidence.
A Tucson personal injury lawyer at the Showard Law Firm can help if you have been the victim of one of the products. More women are stepping forward and telling their stories, and these products have caused horrific injury to patients. Contact us today if you have been implanted with Bard transvaginal mesh.